Everything in the market is going down big today: stocks, precious metals and oil.........is this the start of the paper market heading to where it should be?
Bought Vale SA /ADR @11.78 .off the hook call volume today I'll hold for a few weeks.
Very conservative play not my normal thing...Just a call volume play.
Worth watching...They are doing some far out science and the growth is impressive.
Twist Bioscience Corporation (TWST)
62.51-0.53 (-0.84%)At close: September 11 4:00PM EDT
crazy science,
https://finance.yahoo.com/news/twist-bioscience-synthetic-dna-stores-120000866.html
Mist opened up 100% at the bell.. how did you manage to leave money on the table?
Also ABUS was halted not MIST. ABUS was a shot in the dark I'd bet, it's not often you find a stock worth investing in because it's litigating a judgment VS a major Pharma. Pretty unbelievable you found the 1 and 2 % movers in the market today...
If you like real risk in a Pharma in litigation check out MNK
Great book value/great product line and they have a few products in the FDA pipe now (3rd phase) The stock price has been absolutely crushed under massive pressure of litigation.
Bankruptcy around the corner.. the stocks being shorted heavily when a bankruptcy is announced this will go up 15% off the bat.
Decent play if you like chapter 11s' ..Look at the balance sheet it's sorta unreal the stock is 2.34 but the law suits again..could be right up your alley.
Let me know what you think value and maybe from legal standpoint if you will... I'm curious.
https://seekingalpha.com/article/4330363-mallinckrodt-will-never-be-lawsuit-free-until-bankruptcy
MNK finally is about the file..should be an interesting study in bankruptcies ,,this was a great company at one point and they still have massive assets...worth watching this.Stock @ 95 cents this AM
Mallinckrodt preparing bankruptcy filing as heavy bills come due - WSJ
Sep. 25, 2020 3:55 PM ET|About: Mallinckrodt plc (MNK)|By: Jason Aycock, SA News Editor
Mallinckrodt (MNK +1.8%) is readying a bankruptcy filing within weeks, the WSJ reports, saying it may set up a battle over the company's role in the opioid crisis.
The company is talking with key creditors over a restructuring plan covering more than $5B in debt, according to the report - but that framework isn't getting support from states and territories that have sued the company and peers over opioids.
Mallinckrodt appealed a March ruling ordering the company to pay $640M in retroactive rebates tied to MS treatment Acthar, an event impacting its ability to follow through on a $1.6B February settlement with most state attorneys general over opioids.
With the $640M bill close to coming due, a Chapter 11 filing could give the company some financial breathing room.
Maybe the Robinhooders can run it up like they did with Hertz lol.